Eric Dobmeier, President, CEO at CHINOOK THERAPEUTICS, INC. (KDNY), bought 4,000 shares at $13.08 ($53K) on 2020-12-09, disclosed to the SEC on 2020-12-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.24 | 2,000 | $26K | 50.3% |
| 2 | $13.08 | 2,000 | $26K | 49.7% |
| Total | $13.16 avg | 4,000 | $53K | 100% |
| Filing → |
| KDNY | SELL | 2023-02-15 | $385K | — | Filing → |
| KDNY | SELL | 2023-02-01 | $993K | — | Filing → |
| KDNY | SELL | 2022-12-02 | $669K | — | Filing → |